<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hypertrophic scar &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/hypertrophic-scar/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Fri, 12 Jun 2026 11:15:37 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Hypertrophic scar &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study on Improving Burn Scars with Adipose-Derived Stem Cells and Autologous Stromal Vascular Fraction for Patients with Hypertrophic Scarring</title>
		<link>https://clinicaltrials.eu/trial/study-on-improving-burn-scars-with-adipose-derived-stem-cells-and-autologous-stromal-vascular-fraction-for-patients-with-hypertrophic-scarring/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 15:04:26 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-improving-burn-scars-with-adipose-derived-stem-cells-and-autologous-stromal-vascular-fraction-for-patients-with-hypertrophic-scarring/</guid>

					<description><![CDATA[This clinical trial is focused on studying the effects of a new treatment for hypertrophic scarring, which is a type of thick, raised scar that can develop after a burn injury. The study will explore the use of adipose-derived stem cells and autologous stromal vascular fraction to improve the quality of these scars. Adipose-derived stem [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying the effects of a new treatment for <b>hypertrophic scarring</b>, which is a type of thick, raised scar that can develop after a burn injury. The study will explore the use of <b>adipose-derived stem cells</b> and <b>autologous stromal vascular fraction</b> to improve the quality of these scars. Adipose-derived stem cells are special cells taken from fat tissue, while autologous stromal vascular fraction involves using a patient&#8217;s own fat tissue to obtain cells that may help in healing.</p>
<p>The purpose of the study is to investigate whether these treatments can improve scar quality compared to a placebo. Participants will receive injections of either the stem cells, the stromal vascular fraction, or a placebo into their scar tissue. The study will monitor changes in the appearance and structure of the scars over time, using various methods to assess improvements.</p>
<p>Throughout the study, the safety of the treatments will be closely monitored, and any side effects will be documented. The trial aims to provide valuable insights into the potential benefits of using these cell-based therapies for treating hypertrophic scars, which could lead to better outcomes for individuals with burn injuries.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
